Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia - Concepedia

Concepedia

Publication | Open Access

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

DOI Full Paper Access

251

Citations

55

References

2021

Year

Melissa B. Pappalardi, Kathryn Keenan, Mark Cockerill, Wendy A. Kellner, Alexandra Stowell, Christian Sherk, Kristen Wong, Sarath Pathuri, Jacques Briand, Michael Steidel,

Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaPharmacologyImproved TolerabilityPharmacotherapyOncologyRadiation OncologyNovel TherapyDrug DiscoveryMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1